Serum Vaspin Levels as a Biomarker of Insulin Resistance and Diabetic Complications in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Study
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.148 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von P.S. Nalini und 2 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is a major global health challenge associated with insulin resistance, obesity, and microvascular and macrovascular complications. Vaspin (Visceral Adipose TissueDerived Serine Protease Inhibitor) is an adipokine implicated in glucose homeostasis and insulin sensitivity. Its role as a biomarker for diabetic complications remains incompletely understood.
Aim
To estimate serum vaspin levels in patients with T2DM and evaluate its association with obesity, glycemic status, lipid profile, and diabetic complications. Materials and Methods: A hospital-based comparative cross-sectional study was conducted among 50 participants. Twenty-five patients with T2DM and established complications were compared with 25 T2DM patients without complications. Anthropometric parameters, fasting blood sugar (FBS), postprandial blood sugar (PPBS), glycated hemoglobin (HbA1c), lipid profile, renal function parameters, microalbuminuria, and serum vaspin levels were assessed. Statistical analysis was performed using appropriate parametric tests, and correlations were determined.
Results
Patients with diabetic complications demonstrated significantly lower serum vaspin levels compared with those without complications. Serum vaspin exhibited significant negative correlations with BMI, FBS, PPBS, and HbA1c. Triglycerides, LDL cholesterol, urea, creatinine, and microalbuminuria were significantly higher in patients with complications. Reduced serum vaspin levels were associated with increased risk of diabetic complications.
Conclusion
Serum vaspin levels are significantly reduced in T2DM patients with complications and correlate with markers of insulin resistance and metabolic dysfunction. Vaspin may serve as a promising biomarker for early identification and monitoring of diabetic complications.
Zitieren
APA
Nalini, P., M, S., & Pangajam, P. (2026). Serum Vaspin Levels as a Biomarker of Insulin Resistance and Diabetic Complications in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.148
Vancouver
Nalini P, M S, Pangajam P. Serum Vaspin Levels as a Biomarker of Insulin Resistance and Diabetic Complications in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.148
BibTeX
@article{Nalini2026,
author = {Nalini, P.S. and M, Sathiyanindhini and Pangajam, P.},
title = {Serum Vaspin Levels as a Biomarker of Insulin Resistance and Diabetic Complications in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.148}
}
EUVIMED